Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Diclofenac Diethylamine 2.32% Gel vs 1.16% Gel in Acute Ankle Sprain
NCT04052620Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac diethylammonium in Ankle sprain (2 arms), sponsored by GSK. Primary endpoint: Change From Baseline in Pain on Movement at Day 5. Started Oct 2019; status: completed.
02
Drugs
diclofenac diethylammonium
03
Conditions
Ankle sprain
Beyond the preview
Go deeper on NCT04052620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052620.